BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32522932)

  • 1. Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma.
    Nagashio R; Kuchitsu Y; Igawa S; Kusuhara S; Naoki K; Satoh Y; Ichinoe M; Murakumo Y; Saegusa M; Sato Y
    Biomed Res; 2020; 41(3):149-159. PubMed ID: 32522932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma.
    Hagiuda D; Nagashio R; Ichinoe M; Tsuchiya B; Igawa S; Naoki K; Satoh Y; Murakumo Y; Saegusa M; Sato Y
    Biomed Res; 2019; 40(1):17-27. PubMed ID: 30787260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
    Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
    Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
    Xu XY; Lin N; Li YM; Zhi C; Shen H
    Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Expression of Krüppel-like Factor 7 Indicates Unfavorable Clinical Outcomes in Patients with Lung Adenocarcinoma.
    Niu R; Tang Y; Xi Y; Jiang D
    J Surg Res; 2020 Jun; 250():216-223. PubMed ID: 32092599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of blood and lymphatic vessel invasion in pathological stage IA lung adenocarcinoma in the 8th edition of the TNM classification.
    Samejima J; Yokose T; Ito H; Nakayama H; Nagashima T; Suzuki M; Hamanaka R; Yamada K; Masuda M
    Lung Cancer; 2019 Nov; 137():144-148. PubMed ID: 31593845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untangling the evolutionary roots of lung cancer.
    Devarakonda S; Govindan R
    Nat Commun; 2019 Jul; 10(1):2979. PubMed ID: 31278259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
    Lin L; Gu ZT; Chen WH; Cao KJ
    Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
    Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
    Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma.
    Katono K; Sato Y; Kobayashi M; Saito K; Nagashio R; Ryuge S; Igawa S; Nakashima H; Shiomi K; Satoh Y; Ichinoe M; Murakumo Y; Saegusa M; Masuda N
    Oncol Res Treat; 2017; 40(10):594-602. PubMed ID: 28950283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
    Yang SL; Ren QG; Wen L; Hu JL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
    Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
    Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer.
    Noh SJ; Baek HA; Park HS; Jang KY; Moon WS; Kang MJ; Lee DG; Kim MH; Lee JH; Chung MJ
    Pathol Res Pract; 2013 Jun; 209(6):365-70. PubMed ID: 23702379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of G6PD expression and localization in lung adenocarcinoma.
    Nagashio R; Oikawa S; Yanagita K; Hagiuda D; Kuchitsu Y; Igawa S; Naoki K; Satoh Y; Ichinoe M; Murakumo Y; Saegusa M; Sato Y
    Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):38-46. PubMed ID: 29753088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circCRIM1 inhibits invasion and metastasis in lung adenocarcinoma through the microRNA (miR)-182/miR-93-leukemia inhibitory factor receptor pathway.
    Wang L; Liang Y; Mao Q; Xia W; Chen B; Shen H; Xu L; Jiang F; Dong G
    Cancer Sci; 2019 Sep; 110(9):2960-2972. PubMed ID: 31301086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
    Guo T; Zhao S; Li Z; Li F; Li J; Gu C
    Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.